CADET Welcomes New Cohort for Year-Long Entrepreneurship Program
BioVentures welcomes 13 researchers to the newest CADET cohort, expanding the program into a year-long commercialization and entrepreneurship experience.
BioVentures welcomes 13 researchers to the newest CADET cohort, expanding the program into a year-long commercialization and entrepreneurship experience.

BioVentures celebrates a newly issued patent advancing indole-derived compounds designed to overcome therapeutic resistance in cancer by targeting DNA polymerases.

BioVentures honored UAMS researchers, inventors, students and innovation champions during the Innovation Day 2026 Awards & Recognition Ceremony.

A look back at BioVentures Innovation Day 2026, bringing together the UAMS innovation community for a day of connection, collaboration and recognition.
BioVentures is now accepting applications for the third cohort of the AR Health Ventures Accelerator (ARHVA), a program designed to accelerate promising therapeutic and health-related innovations developed at the University of Arkansas for Medical Sciences (UAMS).

BioVentures has established the Dr. Samir Jenkins Innovation Travel Award to honor an exceptional scientist, mentor, entrepreneur, and friend whose work and vision left a lasting impact at UAMS and beyond. Dr. Samir Jenkins, Ph.D.,

The BioVentures Podcast is celebrating two years of sharing the stories, ideas, and people driving innovation at UAMS and across Arkansas.

Technology transfer is evolving rapidly, and collaboration between institutions has never been more important. In Episode 20 of the BioVentures Podcast, we welcome Luna Acosta, Director of Technology Transfer at Arkansas

Turning promising discoveries into products, companies and technologies that improve lives takes more than great ideas. It takes collaboration between researchers, entrepreneurs, investors, industry partners and the organizations that help move innovation

A technology developed at the University of Arkansas for Medical Sciences (UAMS) and licensed through BioVentures is continuing its path toward the clinic as NanO₂, an investigational oxygen therapeutic being developed by NuvOx Therapeutics for the treatment

BioVentures recently welcomed the fourth cohort of participants in the Medical Innovation and Entrepreneurship Honors Track (MIEHT), a four-year honors program that introduces medical students to health care innovation, intellectual property and technology commercialization.

The University of Arkansas at Little Rock’s AI Hackathon and HealthTech Startup Week brought together some of Arkansas’ most promising young innovators to explore how artificial intelligence can help address real-world health care challenges.
DISCLAIMER: Information on this website is not legal advice and should not be relied on as such. The law can change and the information contained on this site may be outdated, so you should always consult an attorney regarding your specific issues in view of the current state of the law. Please contact our team at bioventures@uams.edu if you have any questions and we can help determine a course of action.